Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oramed Pharmaceuticals (ORMP) Shares Outstanding (Diluted Average) (2021 - 2026)

Oramed Pharmaceuticals filings provide 5 years of Shares Outstanding (Diluted Average) readings, the most recent being $42.4 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 3.84% to $42.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.4 million through Dec 2025, up 3.84% year-over-year, with the annual reading at $42.4 million for FY2025, 3.84% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $42.4 million in Q4 2025 for Oramed Pharmaceuticals, down from $42.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $42.9 million in Q2 2025 and bottomed at $28.5 million in Q3 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $39.9 million, with a median of $40.6 million recorded in 2023.
  • Peak annual rise in Shares Outstanding (Diluted Average) hit 4.63% in 2025, while the deepest fall reached 0.81% in 2025.
  • Oramed Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $28.5 million in 2021, then skyrocketed by 36.98% to $39.0 million in 2022, then grew by 4.02% to $40.6 million in 2023, then increased by 0.7% to $40.9 million in 2024, then rose by 3.84% to $42.4 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Shares Outstanding (Diluted Average) are $42.4 million (Q4 2025), $42.8 million (Q3 2025), and $42.9 million (Q2 2025).